MetLife, Inc.

Report azionario NYSE:MET

Capitalizzazione di mercato: US$62.1b

MetLife Crescita futura

Criteri Future verificati 1/6

MetLife prevede che gli utili e i ricavi cresceranno rispettivamente di 16.1% e 4.1% all'anno. Si prevede che l'EPS crescerà di 19% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 15.6% in 3 anni.

Informazioni chiave

16.1%

Tasso di crescita degli utili

19.00%

Tasso di crescita dell'EPS

Insurance crescita degli utili1.1%
Tasso di crescita dei ricavi4.1%
Rendimento futuro del capitale proprio15.61%
Copertura analitica

Good

Ultimo aggiornamento14 Sep 2026

Aggiornamenti recenti sulla crescita futura

Recent updates

Aggiornamento narrativa • Aug 22

MET: Buybacks And New Liquidity Features Will Shape A Balanced Forward Risk Profile

Analysts have raised their price target for MetLife to $104.38 from $100.44, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E that collectively support a higher valuation framework. What’s in the News for MetLife MetLife announced a share repurchase program authorizing up to US$3.0b of common stock buybacks.
Aggiornamento narrativa • Aug 08

MET: Buybacks And Settlement Features Will Shape A Measured Future Risk Reward Balance

Analysts have lifted their price target on MetLife to $100.44 from $97.75, citing updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. These changes collectively support a slightly higher valuation framework.
Seeking Alpha • Aug 06

MetLife's Q2 Earnings Beat Reaffirms The Buy Case As Organic Growth Stands Out

Summary MetLife, Inc. is reaffirmed as a Buy, with quality fundamentals, strong organic growth, and a resilient dividend profile supporting continued bullish momentum. MET's diversified business model, including investment management and group benefits, drives organic growth across multiple segments despite modest profit margin expansion. The balance sheet boasts A-level credit ratings and modest leverage, but significant fixed-income exposure introduces interest rate risk, warranting ongoing monitoring. MET is fairly valued with upside potential into 2026, outperforming the S&P 500 recently, though it is vulnerable to broad market downturns impacting financial stocks. Read the full article on Seeking Alpha
Aggiornamento narrativa • Jul 25

MET: Capital Returns And Flexible Settlement Solutions Will Shape Future Risk Reward Balance

Analysts have raised their price target for MetLife to $97.75 from $95.31, reflecting small revisions to fair value estimates, discount rate, revenue growth, profit margin, and future P/E assumptions. What’s in the News for MetLife MetLife introduced the Non-Qualified Assignment Flex Agreement, a deferred payment solution that uses a funding agreement rather than an annuity to structure non-physical injury settlements with flexible start dates, lump sums, and customized payment schedules.
Aggiornamento narrativa • Jul 11

MET: Capital Returns And Flexible Settlement Solutions Will Shape Future Risk Reward Balance

MetLife's analyst price target has been revised from $92.80 to $95.31. Analysts attribute this change to updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E.
Articolo di analisi • Jun 17

MetLife (MET) Stock Could Be 47% Below Fair Value After New Settlement Product

MetLife’s new deferred payment solution puts product design in focus MetLife (MET) recently introduced the Non-Qualified Assignment Flex Agreement, or NQA-FA, a deferred payment solution that gives attorneys and brokers more control over the timing and structure of non-physical injury settlements. The NQA-FA uses a funding agreement rather than an annuity and supports features such as deferred start dates, lump sums and customized payment schedules, potentially broadening how MetLife stock...
Aggiornamento narrativa • Jun 09

MET: Capital Returns And Product Flexibility Will Shape Future Risk Reward Balance

Analysts have raised their price target on MetLife to $92.80 from $89.31, citing updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E estimates. What's in the News MetLife reported Q1 2026 adjusted earnings growth of 18% year over year, with broad top line growth across all operating segments and resilient margins, supported by expanding businesses in Asia, Latin America, Group Benefits, and Retirement and Income Solutions.
Aggiornamento narrativa • May 03

MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential

Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.
Aggiornamento narrativa • Apr 17

MET: Share Repurchases Following Index Exit Will Support Future Upside Potential

Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).
Aggiornamento narrativa • Apr 01

MET: Share Repurchases And Index Exit Will Shape Future Upside Potential

Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.
Aggiornamento narrativa • Mar 18

MET: Share Repurchases Will Support Future Upside Potential

Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).
Aggiornamento narrativa • Mar 04

MET: Buybacks And Retirement Income Agreements Will Drive Future Upside

Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.
Aggiornamento narrativa • Dec 16

MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power

Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.
Aggiornamento narrativa • Nov 07

MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements

Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.
Aggiornamento narrativa • Oct 24

Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead

Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.
Aggiornamento narrativa • Oct 09

International Demand And Digital Transformation Will Fuel Success

Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.
Aggiornamento narrativa • Sep 04

International Demand And Digital Transformation Will Fuel Success

With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.
Seeking Alpha • Feb 11

MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart

Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking Alpha
Seeking Alpha • Nov 26

MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential

Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking Alpha
Seeking Alpha • Sep 23

MetLife: One Of The Best Life Insurance Stocks

Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking Alpha
Seeking Alpha • Jul 09

Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield

Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking Alpha
Seeking Alpha • Jun 26

MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood

Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking Alpha

Previsioni di crescita degli utili e dei ricavi

NYSE:MET - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/202887,2616,921N/AN/A8
12/31/202783,6106,2054,800N/A10
12/31/202679,7474,9694,600N/A10
6/30/202679,3983,44115,55815,558N/A
3/31/202677,5843,43415,51715,517N/A
12/31/202577,0793,17317,09217,092N/A
9/30/202571,9353,63414,62714,627N/A
6/30/202573,0144,09115,22915,229N/A
3/31/202573,4944,30516,53216,532N/A
12/31/202470,9824,22614,59814,598N/A
9/30/202471,3403,56115,16915,169N/A
6/30/202468,7672,70814,47514,475N/A
3/31/202467,5702,16614,02314,023N/A
12/31/202366,9011,38013,72113,721N/A
9/30/202363,4792,35510,84010,840N/A
6/30/202369,8963,03111,67511,675N/A
3/31/202368,7473,54213,03013,030N/A
12/31/202268,7645,09913,04413,044N/A
9/30/202273,2514,72616,08316,083N/A
6/30/202267,8735,14915,27915,279N/A
3/31/202270,9237,63413,14013,140N/A
12/31/202168,6886,65412,34712,347N/A
9/30/202170,4095,30112,40912,409N/A
6/30/202169,5194,41312,69612,696N/A
3/31/202165,0941,11511,28811,288N/A
12/31/202067,8425,19111,63911,639N/A
9/30/202065,5675,60311,66711,667N/A
6/30/202068,2307,12212,02012,020N/A
3/31/202071,6288,738N/A13,561N/A
12/31/201969,6205,721N/A13,786N/A
9/30/201968,1397,195N/A9,906N/A
6/30/201965,7505,923N/A9,293N/A
3/31/201969,4385,084N/A12,514N/A
12/31/201867,9414,982N/A11,738N/A
9/30/201868,1125,244N/A12,487N/A
6/30/201867,9805,235N/A13,688N/A
3/31/201862,1195,197N/A11,481N/A
12/31/201762,3084,893N/A12,283N/A
9/30/201759,2631,893N/A15,876N/A
6/30/201758,9082,044N/A14,069N/A
3/31/201757,2632,229N/A14,959N/A
12/31/201660,7323,481N/A14,774N/A
9/30/201665,2094,994N/A13,733N/A
6/30/201667,2555,169N/A13,445N/A
3/31/201669,9525,219N/A13,356N/A
12/31/201561,2573,891N/A14,052N/A
9/30/201571,8885,857N/A14,953N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di MET ( 16.1% all'anno) è superiore al tasso di risparmio ( 3.7% ).

Guadagni vs Mercato: Si prevede che gli utili di MET ( 16.1% all'anno) cresceranno più lentamente rispetto al mercato US ( 17.1% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di MET cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di MET ( 4.1% all'anno) crescerà più lentamente rispetto al mercato US ( 13.3% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di MET ( 4.1% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di MET sarà basso tra 3 anni ( 15.6 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/09/15 16:20
Prezzo dell'azione a fine giornata2026/09/15 00:00
Utili2026/06/30
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.

Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

MetLife, Inc. è coperta da 33 analisti. 11 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Jacob KilsteinArgus Research Company
Jay GelbBarclays
"Alex ScottBarclays